Does OXALIPLATIN Cause Malignant neoplasm progression? 1,189 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,189 reports of Malignant neoplasm progression have been filed in association with OXALIPLATIN (Oxaliplatin). This represents 2.1% of all adverse event reports for OXALIPLATIN.
1,189
Reports of Malignant neoplasm progression with OXALIPLATIN
2.1%
of all OXALIPLATIN reports
302
Deaths
247
Hospitalizations
How Dangerous Is Malignant neoplasm progression From OXALIPLATIN?
Of the 1,189 reports, 302 (25.4%) resulted in death, 247 (20.8%) required hospitalization, and 44 (3.7%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OXALIPLATIN. However, 1,189 reports have been filed with the FAERS database.
What Other Side Effects Does OXALIPLATIN Cause?
Diarrhoea (4,963)
Nausea (4,250)
Neuropathy peripheral (3,662)
Off label use (3,603)
Neutropenia (3,391)
Vomiting (3,383)
Disease progression (3,370)
Thrombocytopenia (2,886)
Dyspnoea (2,779)
Pyrexia (2,269)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which OXALIPLATIN Alternatives Have Lower Malignant neoplasm progression Risk?
OXALIPLATIN vs OXAPROZIN
OXALIPLATIN vs OXAZEPAM
OXALIPLATIN vs OXCARBAZEPINE
OXALIPLATIN vs OXITRIPTAN
OXALIPLATIN vs OXOMEMAZINE